120 - Prevalence of Hepatitis B Co-infection in People with HIV by Birth Cohort– Potential Impact of HBV Vaccination Availability

Thursday, October 17, 2024

12:15 PM – 12:20 PM US PT

Location: Halls JK - Arena 2

Rapid Fire Presenter(s)

Claire (So Jeong) Lee, MD (she/her/hers)

Resident
University of Toronto, Department of Medicine
Toronto, Ontario, Canada

Co-Author(s)

Tarfa I. Verinumbe, MD MPH (he/him/his)

Research Fellow
Johns Hopkins University
Baltimore, Maryland, United States
AF

Anthony Fojo, MD MHS

Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
JJ

Joyce L. Jones, MD, MS

Assistant Professor
Johns Hopkins University School of Maryland
Baltimore, Maryland, United States
JK

Jeanne Keruly, NP

Assistant Professor
The Johns Hopkins University School of Medicine
Baltimore, MD, United States
LS

LaQuita N. Snow, CRNP/DNP

Johns Hopkins University
Baltimore, Maryland, United States
RM

Richard Moore, MD

Professor
Johns Hopkins University
Baltimore, MD, United States
Mark S. Sulkowski, MD (he/him/his)

Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD, United States
Oluwaseun Falade-Nwulia, MBBS ,MPH (she/her/hers)

Associate Professor
Johns Hopkins University
Baltimore, MD, United States

Disclosure(s):

Claire (So Jeong) Lee, MD: No financial relationships to disclose

Joyce L. Jones, MD, MS: No financial relationships to disclose

Mark S. Sulkowski, MD: AbbVie: Advisor/Consultant (); Aligos Therapeutics: Advisor/Consultant (); Gilead: Advisor/Consultant (); GSK: Advisor/Consultant (), Grant/Research Support (); Janssen: Grant/Research Support (); Precision Biosciences: Advisor/Consultant (); Vir: Grant/Research Support (); Virion: Advisor/Consultant ()

Oluwaseun Falade-Nwulia, MBBS ,MPH: Abbvie Inc: Grant/Research Support (); Gilead Sciences: Advisor/Consultant ()